Anastomosis Devices Market Size, Share & Trends Analysis Report By Product (Disposable, Reusable), By Application (Cardiovascular Surgery, Gastrointestinal Surgery), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Anastomosis Devices Market Size & Trends

The global anastomosis devices market size was estimated at USD 3.98 billion in 2023 and is projected to grow at a CAGR of 5.6% from 2024 to 2030. The increase in the number of surgical procedures, a rise in the prevalence of chronic diseases and technological advancements in anastomosis devices are the key trends driving the market growth. Lifestyle-related conditions such as cardiac diseases, diabetes, hypertension, obesity, and cancer are contributing to the growth in demand for these devices. According to the article published by the National Center for Chronic Disease Prevention & Health Promotion, in August 2023, approximately 60% of the population living in the U.S. were suffering from at least one chronic condition such as heart ailment, cancer, stroke, and diabetes.

The rising number of surgical procedures, such as Coronary Artery Bypass Graft (CABG), organ transplantation surgery, dialysis access surgery, intestinal bypass surgery, and colectomy, is anticipated to drive market growth over the forecast period. With the growing prevalence of cardiovascular & heart diseases, a large number of CABG surgeries are being conducted. The study published by the National Library of Medicine in August 2023 reports that CABG is the most typical surgical process, and around 400,000 CABG surgeries are performed annually. Moreover, the growing number of individuals undergoing organ transplantations is also expected to boost the demand for anastomosis devices over the forecast period. According to the article published by the United Network for Organ Sharing, in January 2023, around 42,887 organ transplants were performed in the U.S. in 2022, which demonstrated an increase of 3.7% over 2021.

Technological advancements, such as developing novel products by modifying shapes and designs, are anticipated to increase the adoption of anastomosis devices. In addition, key manufacturers are using various technologies such as 3D stapling technology, gripping surface technology, and tri-staple technology in these devices. Major companies in the market are focusing on developing innovative devices and technologies that can be used for anastomosis. For instance, in January 2022, Seger Surgical Solutions initiated the development of its laparoscopic bowel closure device, LAP IA 60, for intracorporeal anastomosis. This device can close, align, and staple the common opening for intracorporeal anastomosis securely, quickly, and without the requirement for suturing. This next-generation device can close the enterotomy within two minutes. Such product advancements are expected to boost the adoption of anastomosis devices in the coming decade.

Moreover, the demand for anastomosis devices is also expected to increase due to the growing geriatric population and healthcare expenditure. According to the National Bureau of Statistics of China, in 2023, individuals aged 60 & above accounted for 19.8% of the population. Around 330 million individuals in China are affected by CVDs, 45.3 million by peripheral artery disease, 11.39 million by coronary heart disease, including 13 million strokes, 5 million pulmonary heart disease, 4.87 million atrial fibrillation, 2.5 million rheumatic heart disease, 8.9 million heart failure, 2 million congenital heart disease, and 245 million hypertension cases. This rising prevalence of cardiovascular conditions among the population needs surgical attention, which is expected to drive the market growth of anastomosis devices.

Market Concentration & Characteristics

The use of biodegradable materials, such as polyglycolic acid, has reduced the risk of infection and improved the healing process. Key players operating in the market are focusing on technological innovations and developing advanced technology-based devices to gain a significant revenue share. Companies are focusing on Gripping Surface Technology (GST), magnetic anastomosis technology, and 3D stapling technology for developing anastomosis devices that can reduce leaks at the staple line and provide less invasive solutions for surgeons & patients.

The market is characterized by a moderate level of merger and acquisition (M&A) activity. Some of the notable mergers and acquisitions in the market include the acquisition of Dextera Surgical by AesDex LLC, the acquisition of Ascyrus Medical by CryoLife, and the acquisition of Vascular Architects by LeMaitre Vascular. Additionally, in September 2020, Medtronic acquired a privately held medical device company, Avenu Medical. The Avenu Medical focuses on developing the endovascular Arteriovenous (AV) fistulae. The Ellipsys vascular access system of Avenu Medical is useful for creating a proximal radial artery to perforating vein anastomosis.

Regulations play a crucial role in shaping the global market. The medical device industry is highly regulated to ensure patient safety, product efficacy, and quality standards. Regulatory bodies such as the Food and Drug Administration (FDA) in the U.S. and the European Medicines Agency (EMA) in Europe have specific requirements that manufacturers of anastomosis devices must meet before commercializing their products. The companies in this market are gaining favorable support from the regulatory bodies for innovative technologies used in anastomosis devices. In November 2020, a clinical-stage medical device firm, GI Windows Medical Corp., received the Breakthrough Device Designation from the U.S. FDA for its anastomosis device. This self-forming magnetic compression device is developed to assist surgeons in providing less invasive solutions using magnetic anastomosis technology

The global market faces competition from various product substitutes. Some common product substitutes in the market include traditional surgical sutures which are commonly used for creating anastomoses in various surgical procedures, surgical staplers and tissue sealants & adhesives. The availability of these substitutes can impact the adoption rates of traditional anastomosis devices in the market. Surgeons and healthcare providers may choose substitutes based on factors such as cost-effectiveness, ease of use, patient outcomes, and clinical preferences.

Regional expansion is a key factor in the growth of the market. The market is expanding rapidly in developed regions, such as North America and Europe, due to the high adoption rate of advanced medical technologies. These regions are home to several leading medical device manufacturers, and companies are investing heavily in R&D activities to develop innovative anastomosis devices. Companies are focused on expanding their regional presence by establishing partnerships, collaborations, and acquisitions. For instance, in March 2023, Peters Surgical acquired the German company Catgut. This acquisition, leveraging industrial, R&D, and commercial expertise, will empower Peters Surgical to reinforce its leadership across Europe while fortifying its global presence in cardiovascular and digestive medical devices.

Product Insights

The disposable segment dominated the market with a revenue share of 88.6% in 2023, owing to the availability of an array of disposable anastomotic products and greater market penetration. The majority of key players are involved in the production of disposable type of products. These products reduce the risk of cross-contamination, Surgical Site Infections (SSI), and other Healthcare-associated Infections (HAI). Another advantage of disposable anastomotic devices over reusable ones is that they reduce reprocessing costs and speed up the process. Some of the commercially available disposable anastomosis devices include Valtrac, DST series EEA staplers, Mitroflow Valsalva Conduit, Endo GIA Reload with Tri-Staple Technology and Endo Stitch by Covidien, Ltd. Medtronic’s Multifire Endo TA 30 Staplers and Reloads are the disposable reloadable laparoscopic stapler for resection, transection, and anastomosis with titanium staples which is designed to provide precise and accurate staple formation, ensuring secure closure of tissues during surgical procedures.

The reusable segment is expected to grow with the fastest CAGR during the forecast period, owing to the environment-friendly and cost-effective benefits associated with reusable instruments. Reusable anastomosis devices are medical instruments that can be sterilized and used multiple times, which generates less waste. They are often used in surgical procedures that require a more robust and long-lasting connection between the two structures. The cost-benefit allied due to multiple uses of the same device is expected to fuel the market during the forecast period.

Application Insights

The cardiovascular surgery segment dominated the market with the largest revenue share in 2023. Anastomosis devices are often used in cardiovascular surgeries to connect blood vessels during surgical procedures as they reduce the risk of complications during surgery. The growth of the cardiovascular surgery segment is attributable to the high prevalence of cardiovascular disease, the rising geriatric population, and the advancements in surgical techniques and technology. Cardiovascular diseases such as coronary artery disease, peripheral artery disease, and vascular diseases are the leading causes of death worldwide.

According to the report published by the World Heart Federation on May 2023, deaths from CVD have risen from 12.1 million in 1990 to 20.5 million in 2021 worldwide. CVD emerged as the topmost cause of fatalities worldwide in 2021. As per the observation, four out of every five CVD deaths happened in Low- and Middle-Income Countries (LMICs). The report also cited that high blood pressure, air pollution, tobacco use, and elevated LDL cholesterol levels were some of the significant factors that contributed to the high number of CVD fatalities.

The gastro-intestinal surgery segment is expected to grow at a significant CAGR during the forecast period. The prevalence of gastrointestinal disorders, such as inflammatory bowel disease, colorectal cancer, and diverticulitis, has contributed to the increasing demand for gastrointestinal surgery. The study published by the American Gastroenterological Association in April 2020 found that 40% of individuals worldwide have Functional Gastrointestinal Disorders (FGIDs). Anastomosis devices are used in gastrointestinal surgery to make it safer, more effective, and less invasive. They allow surgeons to perform complex procedures with greater precision and accuracy, resulting in better patient outcomes.

End-use Insights

The hospitals segment dominated the market with the largest revenue share in 2023 owing to the availability of advanced medical equipment, skilled professionals who can easily perform surgeries and superior patient care. People prefer to undergo surgeries in hospitals as they perceive it to be a safer environment and have access to emergency medical care if needed. Moreover, medical insurance coverage and reimbursements play a significant role in hospital surgeries contributing to the largest revenue share in market. According to the data from the Brazilian Federation of Hospitals (FBH) and the National Confederation of Health (CNSaúde), out of 7,191 hospitals in Brazil, 62% are privately owned. As of 2022, the country boasts 710 health insurance providers, 427,097 hospital beds, 546,000 physicians, 402,000 dentists, and 90,9000 drugstores.

The ambulatory care centers & clinics segment is expected to grow at the fastest CAGR during the forecast period. The increasing demand for minimally invasive surgeries, which require less hospital stay & faster recovery times, the rising prevalence of chronic diseases, and the adoption of advanced surgical methods are driving the market growth. Ambulatory care centers and clinics are well-equipped to handle surgical procedures and are therefore expected to see a surge in demand for their services.

Regional Insights

The anastomosis devices market growth in North America is attributable to the high healthcare spending, the presence of well-established hospitals, and the significant presence of key players in the U.S. According to the National Center for Biotechnology Information (NCBI), in 2020, around 40 to 50 million surgeries were conducted in the U.S. This surge in surgical procedures is expected to increase the demand for anastomosis devices, propelling regional growth. Moreover, according to the Monmouth Medical Center (MMC), over 600,000 surgical procedures are performed in the U.S. annually to treat several colon diseases.

U.S. Anastomosis Devices Market Trends

Rapid technological advancements and the presence of key manufacturers in the U.S. undertaking various initiatives, such as product approvals, product launches, mergers & acquisitions, to gain a competitive edge are expected to contribute to market growth. According to the article published by the United Network for Organ Sharing, in January 2023, around 42,887 organ transplants were performed in the U.S. in 2022, which demonstrates an increase of 3.7% over 2021.

Middle East and Africa Anastomosis Devices Market Trends

The anastomosis devices market in the Middle East and Africa is expected to grow at the fastest CAGR during the forecast period owing to the rising focus of industry participants on the regional market, the presence of well-established medical infrastructure, and the increasing prevalence of chronic conditions. Moreover, the rising geriatric population in the Middle East and Africa is also a significant driver for the anastomosis devices market. Investments in healthcare facilities, training programs for healthcare professionals, and awareness campaigns about the benefits of early detection and treatment of diseases are all contributing to the expansion of the Anastomosis devices market in the Middle East and Africa.

South Africa Anastomosis Devices Market Trends

The local and international market players are undertaking several initiatives, such as improving distribution networks, to increase their presence in South Africa. For instance, in November 2023, Peters Surgical, a major medical equipment manufacturer, revealed VERTICE HEALTHCARE as their exclusive distributor in South Africa for Clips, Sutures, and Glue. Such distribution developments are anticipated to drive the anastomosis devices market in South Africa.

Key Anastomosis Devices Company Insights

Some of the key players operating in the market include Medtronic; Ethicon US, LLC; Peters Surgical. s

• Medtronic is a global company in medical technology, solutions and services which offers a range of anastomosis devices through its minimally invasive therapies group. Medtronic’s anastomosis devices portfolio includes products such as LigaSure, Signia Stapling System, DuraSeal, Vessel Sealers and Handheld Surgical Staplers

• Mizuho Medical Co., Ltd is a medical devices company that specializes in medical devices, including products for surgical procedures such as anastomosis. Mizuho Medical Co., Ltd offers a diverse portfolio of anastomosis devices, including staplers, sutures, and other specialized instruments used in surgical procedures.

Recent Developments

• In April 2022, the Synovis Micro Companies Alliance, Inc., a subsidiary of Baxter, received approval from the U.S. FDA for its GEM FLOW COUPLER Monitor device. This device is useful in the end-to-end anastomosis of veins and arteries.

• In January 2022, Seger Surgical Solutions Ltd. initiated the development of LAP IA 60, an intracorporeal anastomosis laparoscopic device.

• In March 2021, ETHICON, Inc. (Johnson & Johnson Services, Inc) introduced a new powered surgical stapler, the ECHELON+ Stapler with GST Reloads. This product can improve staple line security & lower intricacies through better staple formation and uniform tissue compression.

Anastomosis Devices Market Report Scope

Global Anastomosis Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global anastomosis devices market report based on product, application and end-use:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Disposable

  • Reusable

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Cardiovascular Surgery

  • Gastrointestinal Surgery

  • Others

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Ambulatory Care Centers and Clinics

• Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait